Global Market Direct’s pharmaceuticals report, “ViiV Healthcare - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- ViiV Healthcare - Brief company overview including business description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of ViiV Healthcare human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across
the globe.- Product profiles for late stage and clinical stage products of ViiV Healthcare with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.- Recent updates of the ViiV Healthcare’s pipeline in the last quarter.- Key discontinued and dormant projects.- Latest news and deals relating to the products.

Reasons to buy

- Evaluate ViiV Healthcare’s strategic position with total access to detailed information on its product pipeline.- Assess the growth potential of ViiV Healthcare in its therapy areas of focus.- Identify new drug targets and therapeutic classes in the ViiV Healthcare’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.- Exploit collaboration and partnership opportunities with ViiV Healthcare.- Avoid Intellectual Property Rights related issues.- Explore the dormant and discontinued projects of ViiV Healthcare and identify potential opportunities in those areas.
SHOW LESS
READ MORE >

PLEASE SELECT A FORMAT

Quick Help:
This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

EUR 942USD 1,000GBP 662

SITE LICENSE Electronic (PDF)

Quick Help:
This company profile will be emailed to you. The company profile is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

EUR 1414USD 1,500GBP 994

ENTERPRISEWIDE Electronic (PDF)

Quick Help:
This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.